Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Physical Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05188066
What this trial is testing

Study of Pregnancy Pathologies Associated With Placental Abnormalities

Who this might be right for
Pre-eclampsiaPre-TermFetal Growth Retardation
University Hospital, Grenoble 800
Early research (Phase 1)Study completedNCT03387566
What this trial is testing

Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Huabo Biopharm Co., Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT00994123
What this trial is testing

MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merrimack Pharmaceuticals 162
Not applicableEnded earlyNCT03857659
What this trial is testing

Serial Third Trimester Abdominal Circumference and Amniotic Fluid Measurements Versus Routine Care

Who this might be right for
Fetal Growth AbnormalityAmniotic Fluid; Disorder
The University of Texas Health Science Center, Houston 113
Not applicableStudy completedNCT00001738
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) in Uveitis

Who this might be right for
Macular Edema, CystoidUveitis
National Eye Institute (NEI) 60
Not applicableActive Not RecruitingNCT05632055
What this trial is testing

MiRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

Who this might be right for
Gestational Diabetes
Chiang Mai University 160
Early research (Phase 1)Study completedNCT02540876
What this trial is testing

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant NeoplasmSolid NeoplasmUnresectable Malignant Neoplasm
University of Chicago 12
Not applicableStudy completedNCT01329523
What this trial is testing

Compare Genetic Variations of IGF-I and IGF-II

Who this might be right for
Dementia
Avera McKennan Hospital & University Health Center 50
Testing effectiveness (Phase 2)Study completedNCT00193661
What this trial is testing

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Who this might be right for
Primary or Secondary HypogonadismConstitutional Delay in Growth and Puberty (CDGP)
Solvay Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT01945866
What this trial is testing

Phase II Combination Steroid and Anti-VEGF for Persistent DME

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 129
Early research (Phase 1)Not Yet RecruitingNCT06385522
What this trial is testing

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Who this might be right for
NHLCutaneous T Cell LymphomaPeripheral T-cell Lymphoma
Boston Immune Technologies and Therapeutics 37
Testing effectiveness (Phase 2)Study completedNCT02357342
What this trial is testing

Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD

Who this might be right for
Age-Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 40
Testing effectiveness (Phase 2)Study completedNCT01438086
What this trial is testing

Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack

Who this might be right for
Heart FailureMyocardial Infarction
University College Cork 47
Large-scale testing (Phase 3)Active Not RecruitingNCT03071666
What this trial is testing

Vitamin B12 Supplementation During Pregnancy on Cognitive Development

Who this might be right for
Pregnancy RelatedVitamin B 12 DeficiencyAnemia
Centre For International Health 800
Not applicableStudy completedNCT03040388
What this trial is testing

Exploring Effects of Electroconvulsive Therapy on the Human Brain in Depression - The Danish ECT/MRI Study

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major
University of Copenhagen 26
Testing effectiveness (Phase 2)Ended earlyNCT00817362
What this trial is testing

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2 Positive Breast CancerMetastatic Breast Cancer+1 more
Infinity Pharmaceuticals, Inc. 29
Large-scale testing (Phase 3)Study completedNCT01661946
What this trial is testing

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

Who this might be right for
Diabetic Macular Edema
Queen's University 10
Very early researchUnknownNCT06205979
What this trial is testing

Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents

Who this might be right for
Diabetic Macular Edema
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT02988986
What this trial is testing

TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast Cancer
The Methodist Hospital Research Institute 28
Next Page